Literature DB >> 15545852

Risk of bacterial infection in previously healthy respiratory syncytial virus-infected young children admitted to the intensive care unit.

Adrienne G Randolph1, Lindsay Reder, Janet A Englund.   

Abstract

OBJECTIVE: To evaluate the risk of bacterial infection and use of antibiotics in otherwise healthy children infected with respiratory syncytial virus (RSV) admitted to the intensive care unit (ICU).
METHODS: Demographics, clinical information, interventions and outcomes were extracted from the charts of consecutive patients with laboratory-confirmed RSV infection at Children's Hospital, Boston from October 1990 through April 2002. Patients born at <36 weeks gestational age or with preexisting medical conditions were excluded.
RESULTS: The median age of the 165 previously healthy infants infected with RSV was 42 days. Almost all patients received supplementary FiO2, and 63 (38.2%) patients required mechanical ventilator support. No patients died. The median length of stay was 3 days in the ICU and 7 days in the hospital. Most patients had bacterial cultures sent: 155 (93.9%), blood cultures; 121 (73.3%), urine cultures; and 85 (51.5%) cerebrospinal fluid cultures. Only 1 blood culture was positive, and 1 potential urinary tract infection was identified in a patient with a negative urinalysis. All intubated patients and 80.4% of nonintubated patients received antibiotic therapy.
CONCLUSIONS: In otherwise healthy infants admitted to the ICU with RSV infection, bacteremia, urinary tract infection and meningitis are uncommon. Although bacterial pneumonia in this cohort may be more prevalent, overdiagnosis is common.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15545852      PMCID: PMC3705636          DOI: 10.1097/01.inf.0000143647.88873.66

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  13 in total

1.  Use of respiratory syncytial virus testing could safely eliminate many sepsis evaluations.

Authors:  J A Antonow; C L Byington
Journal:  Arch Pediatr Adolesc Med       Date:  1999-12

2.  Quality assurance of gram-stained direct smears.

Authors:  R C Bartlett; J Tetreault; J Evers; J Officer; J Derench
Journal:  Am J Clin Pathol       Date:  1979-12       Impact factor: 2.493

3.  Clinical and financial benefits of rapid detection of respiratory viruses: an outcomes study.

Authors:  J Barenfanger; C Drake; N Leon; T Mueller; T Troutt
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

4.  Concurrent serious bacterial infections in 2396 infants and children hospitalized with respiratory syncytial virus lower respiratory tract infections.

Authors:  Kevin Purcell; Jaime Fergie
Journal:  Arch Pediatr Adolesc Med       Date:  2002-04

5.  Utility of sepsis evaluation in infants 90 days of age or younger with fever and clinical bronchiolitis.

Authors:  Elliot Melendez; Marvin B Harper
Journal:  Pediatr Infect Dis J       Date:  2003-12       Impact factor: 2.129

6.  Prevalence of serious bacterial infections in febrile infants with respiratory syncytial virus infection.

Authors:  M Olivia Titus; Seth W Wright
Journal:  Pediatrics       Date:  2003-08       Impact factor: 7.124

7.  Risk of serious bacterial infection in young febrile infants with respiratory syncytial virus infections.

Authors:  Deborah A Levine; Shari L Platt; Peter S Dayan; Charles G Macias; Joseph J Zorc; William Krief; Jeffrey Schor; David Bank; Nancy Fefferman; Kathy N Shaw; Nathan Kuppermann
Journal:  Pediatrics       Date:  2004-06       Impact factor: 7.124

8.  Serious bacterial infections in febrile infants 1 to 90 days old with and without viral infections.

Authors:  Carrie L Byington; F Rene Enriquez; Charles Hoff; Richard Tuohy; E William Taggart; David R Hillyard; Karen C Carroll; John C Christenson
Journal:  Pediatrics       Date:  2004-06       Impact factor: 7.124

9.  Hospitalization for lower respiratory tract illness in infants: variation in rates among counties in New York State and areas within Monroe County.

Authors:  K M McConnochie; K J Roghmann; G S Liptak
Journal:  J Pediatr       Date:  1995-02       Impact factor: 4.406

10.  Risk of secondary bacterial infection in infants hospitalized with respiratory syncytial viral infection.

Authors:  C B Hall; K R Powell; K C Schnabel; C L Gala; P H Pincus
Journal:  J Pediatr       Date:  1988-08       Impact factor: 4.406

View more
  29 in total

1.  Pulmonary bacterial co-infection in children ventilated for severe respiratory syncytial virus bronchiolitis is common.

Authors:  Kentigern Thorburn; Hendrik Van Saene
Journal:  Intensive Care Med       Date:  2006-12-20       Impact factor: 17.440

2.  Pulmonary abscess of viral-bacterial etiology in a neonate.

Authors:  Ville Peltola; Erkki Svedström; Matti Waris; Terho Heikkinen; Olli Ruuskanen
Journal:  Eur J Pediatr       Date:  2007-01-11       Impact factor: 3.183

3.  The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.

Authors:  John S Bradley; Carrie L Byington; Samir S Shah; Brian Alverson; Edward R Carter; Christopher Harrison; Sheldon L Kaplan; Sharon E Mace; George H McCracken; Matthew R Moore; Shawn D St Peter; Jana A Stockwell; Jack T Swanson
Journal:  Clin Infect Dis       Date:  2011-08-31       Impact factor: 9.079

4.  Atypical Presentations of Respiratory Syncytial Virus Infection: Case Series.

Authors:  Nawal Al-Maskari; Jalila Mohsin; Amal Al-Maani; Nabil Al-Macki; Suad Al-Ismaili
Journal:  Sultan Qaboos Univ Med J       Date:  2016-02-02

Review 5.  Viral Bacterial Interactions in Children: Impact on Clinical Outcomes.

Authors:  Alejandro Diaz-Diaz; Cristina Garcia-Maurino; Alejandro Jordan-Villegas; Jeffrey Naples; Octavio Ramilo; Asuncion Mejias
Journal:  Pediatr Infect Dis J       Date:  2019-06       Impact factor: 2.129

6.  The impact of prophylaxis on paediatric intensive care unit admissions for RSV infection: a retrospective, single-centre study.

Authors:  Michelle L Butt; Amanda Symington; Marianne Janes; Louann Elliott; Susan Steele; Bosco A Paes
Journal:  Eur J Pediatr       Date:  2010-12-22       Impact factor: 3.183

7.  Infant baboons infected with respiratory syncytial virus develop clinical and pathological changes that parallel those of human infants.

Authors:  James F Papin; Roman F Wolf; Stanley D Kosanke; Justin D Jenkins; Sara N Moore; Michael P Anderson; Robert C Welliver
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-02-15       Impact factor: 5.464

8.  High incidence of pulmonary bacterial co-infection in children with severe respiratory syncytial virus (RSV) bronchiolitis.

Authors:  K Thorburn; S Harigopal; V Reddy; N Taylor; H K F van Saene
Journal:  Thorax       Date:  2006-03-14       Impact factor: 9.139

9.  A model of the costs of community and nosocomial pediatric respiratory syncytial virus infections in Canadian hospitals.

Authors:  Philip Jacobs; Douglas Lier; Katherine Gooch; Katharina Buesch; Michelle Lorimer; Ian Mitchell
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

10.  Respiratory viruses in bronchiolitis and their link to recurrent wheezing and asthma.

Authors:  Jonathan M Mansbach; Carlos A Camargo
Journal:  Clin Lab Med       Date:  2009-12       Impact factor: 1.935

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.